CAGNACCI, Angelo
 Distribuzione geografica
Continente #
NA - Nord America 26572
EU - Europa 16369
AS - Asia 2161
Continente sconosciuto - Info sul continente non disponibili 25
SA - Sud America 23
OC - Oceania 6
AF - Africa 4
Totale 45160
Nazione #
US - Stati Uniti d'America 26537
GB - Regno Unito 7354
DE - Germania 1991
IT - Italia 1802
UA - Ucraina 1762
SE - Svezia 1599
CN - Cina 1105
TR - Turchia 838
FI - Finlandia 724
BG - Bulgaria 644
FR - Francia 198
RU - Federazione Russa 131
IN - India 70
IR - Iran 43
PL - Polonia 34
CA - Canada 28
KR - Corea 27
ES - Italia 24
EU - Europa 24
VN - Vietnam 24
NL - Olanda 23
MY - Malesia 20
BE - Belgio 17
CH - Svizzera 15
BR - Brasile 13
DK - Danimarca 10
PT - Portogallo 10
CL - Cile 9
JP - Giappone 8
GR - Grecia 5
IL - Israele 5
MX - Messico 5
AU - Australia 4
ID - Indonesia 4
PH - Filippine 4
RO - Romania 4
CZ - Repubblica Ceca 3
HK - Hong Kong 3
HU - Ungheria 3
AE - Emirati Arabi Uniti 2
AT - Austria 2
BZ - Belize 2
EG - Egitto 2
IE - Irlanda 2
MC - Monaco 2
NZ - Nuova Zelanda 2
PK - Pakistan 2
RS - Serbia 2
SM - San Marino 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
BH - Bahrain 1
BY - Bielorussia 1
KZ - Kazakistan 1
MD - Moldavia 1
ME - Montenegro 1
NG - Nigeria 1
NO - Norvegia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 45160
Città #
Southend 7063
Jacksonville 4018
Fairfield 3598
Dearborn 2594
Woodbridge 2269
Chandler 1859
Houston 1723
Wilmington 1439
Ashburn 1284
Ann Arbor 1232
Seattle 1179
Cambridge 1144
Nyköping 872
Princeton 756
Sofia 644
Eugene 639
Modena 596
Beijing 542
Izmir 425
Bremen 423
San Diego 369
Des Moines 185
Norwalk 105
Hefei 91
Helsinki 89
Milan 81
Kunming 77
Nanjing 75
San Mateo 46
Falls Church 43
Redwood City 41
Rome 41
Guangzhou 37
Verona 36
Jinan 34
Nanchang 33
Grafing 32
Augusta 30
Kraków 30
London 30
Boardman 27
Philadelphia 23
Dong Ket 22
Saint Petersburg 21
Hebei 20
Ardabil 18
Fuzhou 18
Mountain View 18
Shenyang 18
Bologna 17
Monmouth Junction 17
Brussels 15
Leawood 15
Orsogna 15
Xian 15
San Francisco 12
Andover 11
Palermo 11
Solignano Nuovo 11
Torino 11
Toronto 11
Tulare 11
Baotou 10
Borås 10
Dallas 10
Mumbai 10
New York 10
Chongqing 9
Indiana 9
San Jose 9
Zhengzhou 9
Cornigliano 8
Florence 8
Hanover 8
Aabenraa 7
Bari 7
Catania 7
Kish 7
Napoli 7
Parma 7
Shaoxing 7
Simi Valley 7
Wuhan 7
Aosta 6
Changsha 6
Los Angeles 6
Phoenix 6
Quzhou 6
Selargius 6
Carpi 5
Chaoyang 5
Clearwater 5
Jinhua 5
Lucca 5
Padova 5
Auburn Hills 4
Changchun 4
Chatsworth 4
Chengdu 4
Chicago 4
Totale 36420
Nome #
Differenza tra forma attiva (5-MTHF) e inattiva (acido folico) di folati sulla vasodilatazione di donne in postmenopausa 230
Recommendations for contraception in women with diabetes. AMD-SIC position paper 193
Prediction of age at menopause from assessment of ovarian reserve may be improved by using body mass index and smoking status. 175
The Association between Endometriomas and Ovarian Cancer: Preventive Effect of Inhibiting Ovulation and Menstruation during Reproductive Life 171
Intermenstrual pelvic pain, quality of life and mood 171
Are climacteric complaints associated with risk factors of cardiovascular disease in peri-menopausal women? 169
The ovarian response to controlled stimulation in IVF cycles may be predictive of the age at menopause 165
Combined Hormonal Contraceptive Use and Risk of Breast Cancer in a Population of Women With a Family History 163
Intensity of menstrual pain and estimated angle of uterine flexion 161
Hereditary Ovarian Cancer: Not Only BRCA 1 and 2 Genes 160
La melatonina aumenta la risposta delle gonadotropine al GnRH nelle donne in fase follicolare precoce, ma non nella fase luteale 159
Pharmacokinetic evaluation of desogestrel as a female contraceptive 154
Adenomyosis of the Extrapelvic Portion of the Round Ligament 154
Influence of an oral contraceptive containing drospirenone on insulin sensitivity of healthy women 154
Folate administration decreases oxidative status and blood pressure in postmenopausal women 153
Metabolic impact of combined hormonal contraceptives containing estradiol 153
Medical and patient attitude towards vaginal atrophy: the AGATA study 152
Impact of laparoscopic cystectomy of endometriotic and non-endometriotic cysts on ovarian volume, antral follicle count (AFC) and ovarian doppler velocimetry 150
Effects of melatonin on vascular reactivity, catecholamine levels, and blood pressure in healthy men. 144
Menopause, estrogens, progestins, or their combination on body weight and anthropometric measures. 144
Prospective measurement of blood pressure and heart rate over 24 h in women using combined oral contraceptives with estradiol 144
High-dose short-term folate administration modifies ambulatory blood pressure in postmenopausal women. A placebo-controlled study. 143
Role of melatonin in circadian rhythm at menopause 142
Relation between body mass index and endothelium-dependent vasodilatation in healthy postmenopausal women. 142
Body composition and resting metabolic rate of perimenopausal women using continuous progestogen contraception 142
Effect of oral contraceptives containing estradiol and nomegestrol acetate or ethinyl-estradiol and chlormadinone acetate on primary dysmenorrhea 141
Relation between oxidative stress and climacteric symptoms in early postmenopausal women 140
Seasonal trend of acute pelvic inflammatory disease 140
Evaluation of Transvaginal Ultrasound plus CA-125 Measurement and Prophylactic Salpingo-Oophorectomy in Women at Different Risk Levels of Ovarian Cancer: The Modena Study Group Cohort Study 140
Insulin sensitivity and lipid metabolism with oral contraceptives containing chlormadinone acetate or desogestrel: a randomized trial 139
Reproductive risk factors in women with family history of breast cancer attending an Italian Family Cancer Clinic 139
Association between urinary incontinence and climacteric symptoms in postmenopausal women 138
Route of administration of contraceptives containing desogestrel/etonorgestrel and insulin sensitivity: a prospective randomized study. 137
Prevalence of menstrual pain in young women: what is dysmenorrhea 136
“In patient” medical abortion versus surgical abortion: patient’s satisfaction 136
Menopausal symptoms and risk factors for cardiovascular disease in postmenopause. 136
Inflammation influences steroid hormone receptors targeted by progestins in endometrial stromal cells from women with endometriosis 134
Cyclic progestin administration increases energy expenditure and decreases body fat mass in perimenopausal women. 133
Dienogest mediates midkine suppression in endometriosis 133
Attitudes and perceptions towards vulvar and vaginal atrophy in Italian post-menopausal women: Evidence from the European REVIVE survey 132
Influence of melatonin and photoperiod on animal and human reproduction 131
Modification of body composition and metabolism during oral contraceptives containing non-androgenic progestins in association with estradiol or ethinyl estradiol 131
European society of contraception statement on contraception in obese women 131
Physiological doses of estradiol decrease nocturnal blood pressure in normotensive postmenopausal women. 131
Melatonin in relation to physiology in adult humans 130
Administration of tibolone decreases 24h heart rate but not blood pressure of post-menopausal women 130
Effects of hormone replacement therapy on C-reactive protein levels in healthy postmenopausal women: Comparison between oral and transdermal administration of estrogen 130
Age at Menopause and Extent of Coronary Artery Disease Among Postmenopausal Women with Acute Coronary Syndromes 130
Modification of blood pressure in postmenopausal women: role of hormone replacement therapy 129
Modification of 24-h ambulatory blood pressure and heart rate during contraception with the vaginal ring: a prospective study. 128
Prolonged melatonin administration decreases nocturnal blood pressure in women. 127
Counseling on vaginal delivery of contraceptive hormones: implications for women's body knowledge and sexual health 127
Progestin suppressed inflammation and cell viability of tumor necrosis factor-α-stimulated endometriotic stromal cells 127
Oral contraceptives and insulin sensitivity 125
Clinical effect of hormonal replacement therapy with estradiol associated with noretisterone or drospirenone. A prospective randomized placebo controlled study 125
Pelvic Pain and Quality of Life of Women With Endometriosis During Quadriphasic Estradiol Valerate/Dienogest Oral Contraceptive. A Patient-Preference Prospective 24-Week Pilot Study 125
Acute modifications in the levels of daytime melatonin do not influence leptin in postmenopausal women. 124
Effect of Estradiol valerate plus dienogest on body composition of healthy women in the menopausal transition: A prospective one-year evaluation 124
Altered neuroendocrine regulation of luteinizing hormone secretion in postmenopausal women with Parkinson's disease. 124
Amplification of pulsatile LH secretion by exogenous melatonin in women 124
Regulation of the 24-hour rhythm of body temperature in menstrual cycles with spontaneous and gonadotropin-induced ovulation. 122
Combined oral contraceptive containing drospirenone does not modify 24-h ambulatory blood pressure but increases heart rate in healthy young women: prospective study 122
Biometrical threshold of biparietal diameter for certain fetal sex assignment by ultrasound. 121
Lack of any estrogenic effect of ipriflavone in postmenopausal women. 120
Efficacia del nomegestrolo acetato, derivato del 19-Nor progesterone, nel trattamento dei sintomi premestruali: uso in casi selezionati con fase luteale inadeguata 120
Amplification of pulsatile LH secretion by exogenous melatonin in women. 119
Does dienogest influence the inflammatory response of endometriotic cells? A systematic review 118
Effect of naloxone on body temperature in postmenopausal women with Parkinson's disease. 117
Diagnosis and management of symptoms associated with vulvovaginal atrophy: expert opinion on behalf of the Italian VVA study group* 117
Effect of prolonged administration of transdermal estradiol on flow-mediated endothelium-dependent and endothelium-independent vasodilation in healthy postmenopausal women. 116
Hypothermic effect of melatonin and nocturnal core body temperature decline are reduced in aged women. 114
Melatonin enhances cortisol levels in aged women: reversible by estrogens. 113
Oral contraceptives and bone metabolism. 113
Relation of folates, vitamin B12 and homocysteine to vertebral bone mineral density change in postmenopausal women. A five-year longitudinal evaluation. 113
Endothelin-1 and nitric oxide levels are related to cardiovascular risk factors but are not modified by estradiol replacement in healthy postmenopausal women. A cross-sectional and a randomized cross-over study. 112
ISPOG European Consensus Statement - chronic pelvic pain in women (short version) 112
The effect of light on core body temperature is mediated by melatonin in women. 111
Melatonin: a major regulator of the circadian rhythm of core temperature in humans. 111
The chronic administration of cabergoline normalizes androgen secretion and improves menstrual cyclicity in women with polycystic ovary syndrome. 111
Melatonin in aged women. Possible modulation by estrogens. 111
Reply to: Comment on 'Season of birth influences the timing of menopause' [7] 111
Administration of raloxifene does not influence 24-hour ambulatory blood pressure of postmenopausal women with osteopenia: a double-blind placebo-controlled study. 110
The effect of menopause on blood lipid and lipoprotein levels 110
Potentially beneficial cardiovascular effects of melatonin administration in women. 110
Levonorgestrel administration in emergency contraception: bleeding pattern and pituitary-ovarian function. 109
Treatment with flutamide improves hyperinsulinemia in women with idiopathic hirsutism. 109
Diurnal variation of semen quality in human males. 109
Oral contraceptives and vascular reactivity of great vessels in women. 109
Indirect evidence that estrogen replacement therapy stimulates nitric oxide synthase in postmenopausal women. 109
Contemporaneous melatonin administration modifies the circadian response to nocturnal bright light stimuli. 109
Prevalence and association between objective signs and subjective symptoms of vaginal atrophy: the AGATA study 109
Evidence that an altered prolactin release is consequent to abnormal ovarian activity in polycystic ovary syndrome. 109
Biochemical aspects of hormonal contraception: effects on bone metabolism. 108
Insulin, insulin-like growth factor I (IGF-I) and IGF-II enhance basal and gonadotrophin-releasing hormone-stimulated luteinizing hormone release from rat anterior pituitary cells in vitro. 108
Sympathoadrenal response of postmenopausal women prior and during prolonged administration of estradiol. 108
The impact of reproductive life on breast cancer risk in women with family history or BRCA mutation 108
A role for melatonin in PCOS? 107
Melatonin enhances cortisol levels in aged but not young women. 107
Salmon calcitonin plus intravaginal estriol: an effective treatment for the menopause. 107
Influence of oestradiol and progesterone on pulsatile LH secretion in postmenopausal women 107
Totale 13081
Categoria #
all - tutte 79713
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 79713


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018902 0000 00 49181 7316938248
2018/20196735 213799121667 677527 46833 11445514001261
2019/202011967 863983268561 14592046 2149864 1040358908468
2020/20217771 1065187698653 924334 9651035 2571002356295
2021/20226951 1301268483459 142334 248390 9405737021282
2022/20234581 971572364449 11831017 250 0000
Totale 45709